Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Frailty 12 Neoplasms 11 Ovarian Neoplasms 5 Lymphoma 5 Lung Neoplasms 4 Breast Neoplasms 4 Prostatic Neoplasms 3 Multiple Myeloma 3 Carcinoma, Non-Small-Cell Lung 3 Lymphoma, Large B-Cell, Diffuse 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Treatment Adherence and Compliance 1 Stomach Neoplasms 1 Solid Neoplasm 1 Sarcopenia 1 Sarcoma 1 Recurrence 1 Prostate Cancer Cured 1 Postoperative Complications 1 Pancreatic Neoplasms 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoma, Non-Hodgkin 1

Interventions

Sunitinib 145 Nivolumab 144 pembrolizumab 132 Sorafenib 84 Bevacizumab 77 Everolimus 74 cabozantinib 71 pazopanib 65 Axitinib 65 Ipilimumab 62 aldesleukin 52 Magnetic Resonance Spectroscopy 45 Cyclophosphamide 40 Interleukin-2 38 lenvatinib 37 Specimen Handling 36 Radiosurgery 36 Interferon-alpha 32 atezolizumab 30 temsirolimus 27 belzutifan 24 Gemcitabine 23 fludarabine phosphate 22 avelumab 22 Radiotherapy 19 Interferon alpha-2 19 Biopsy 18 fludarabine 17 durvalumab 17 Nephrectomy 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Geriatric Assessment × Clear all

NCT06745609 2025-01-24

Pre-KiT

Herlev and Gentofte Hospital

Phase NA Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡